Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$255.51 - $362.11 $137,208 - $194,453
-537 Closed
0 $0
Q4 2021

Jan 28, 2022

SELL
$351.38 - $448.68 $10,892 - $13,909
-31 Reduced 5.46%
537 $202,000
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $33,164 - $40,788
-89 Reduced 13.55%
568 $234,000
Q2 2021

Aug 11, 2021

BUY
$294.17 - $371.65 $193,269 - $244,174
657 New
657 $243,000
Q4 2020

Feb 09, 2021

SELL
$222.0 - $252.62 $275,502 - $313,501
-1,241 Closed
0 $0
Q2 2020

Aug 04, 2020

BUY
$118.84 - $189.72 $147,480 - $235,442
1,241 New
1,241 $216,000
Q1 2020

May 14, 2020

SELL
$98.9 - $178.34 $234,096 - $422,130
-2,367 Closed
0 $0
Q4 2019

Feb 11, 2020

SELL
$126.05 - $152.76 $132,226 - $160,245
-1,049 Reduced 30.71%
2,367 $362,000
Q3 2019

Nov 07, 2019

SELL
$125.07 - $143.67 $1,125 - $1,293
-9 Reduced 0.26%
3,416 $452,000
Q2 2019

Aug 01, 2019

BUY
$123.4 - $148.55 $3,948 - $4,753
32 Added 0.94%
3,425 $486,000
Q1 2019

May 10, 2019

SELL
$104.82 - $146.73 $4,821 - $6,749
-46 Reduced 1.34%
3,393 $493,000
Q4 2018

Feb 13, 2019

SELL
$105.09 - $137.23 $13,346 - $17,428
-127 Reduced 3.56%
3,439 $389,000
Q3 2018

Nov 14, 2018

SELL
$112.11 - $134.54 $13,004 - $15,606
-116 Reduced 3.15%
3,566 $479,000
Q2 2018

Aug 10, 2018

SELL
$102.37 - $117.25 $68,792 - $78,792
-672 Reduced 15.43%
3,682 $414,000
Q1 2018

Apr 06, 2018

BUY
$98.19 - $115.2 $37,901 - $44,467
386 Added 9.73%
4,354 $465,000
Q4 2017

Jan 17, 2018

BUY
$100.43 - $118.09 $116,297 - $136,748
1,158 Added 41.21%
3,968 $434,000
Q3 2017

Oct 11, 2017

BUY
$96.72 - $109.26 $271,783 - $307,020
2,810
2,810 $304,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Bar Harbor Wealth Management Portfolio

Follow Bar Harbor Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bar Harbor Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Bar Harbor Wealth Management with notifications on news.